SCHEMBL9924332

SCHEMBL9924332

COC(=O)NC1CCC(N/C(=N\C(=O)c2ccc(OC)cc2)Nc2cc(F)cc(Cl)c2)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.41
MAPK14 Q16539 1/20 0.39
KMT2A Q03164 2/20 0.39
CCR3 P51677 1/20 0.38
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
GRM5 P41594 1/20 0.37
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GRM4 Q14833 1/20 0.37
LHCGR P22888 3/20 0.37
EPHX2 P34913 4/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
EPHX1 P07099 1/20 0.36
CXCR6 O00574 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924090 0.93 APOB (0.40) SLC6A9MAPK14KMT2ATP53MAPT
SCHEMBL9924329 0.92 SLC6A9 (0.40) SLC6A9MAPK14KMT2ACCR3LMNA
SCHEMBL9924069 0.91 GRM4 (0.38) SLC6A9KMT2ATP53MAPTGRM4
SCHEMBL9924070 0.90 GRM4 (0.40) SLC6A9KMT2AGRM4EPHX2MEN1
SCHEMBL9924257 0.90 GRM5 (0.42) KMT2ACCR3LMNAMAPTGRM5
SCHEMBL17206710 0.90 MEN1 (0.38) SLC6A9MAPK14KMT2ALMNATP53
SCHEMBL9924330 0.89 GRM5 (0.47) MAPK14KMT2ACCR3GRM5L3MBTL1
SCHEMBL9924087 0.84 HSD11B1 (0.39) SLC6A9KMT2ALMNAMAPTL3MBTL1
SCHEMBL9924255 0.83 GRM4 (0.36) SLC6A9KMT2AMAPTGRM4EPHX2
SCHEMBL9924331 0.83 NPC1 (0.40) KMT2ACCR3LMNAMAPTGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed